Delivery Order 36F79718D0414-36C77020N0095
Award Date
4/21/20
Potential Completion Date
4/27/20
Potential Value
$406K
Funding Federal Agency
Veterans Integrated Service Network 12
Contracting Federal Agency
Veterans Integrated Service Network 15
Awardee
Neurocrine Biosciences, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92130, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Veterans Affairs Veterans Health Administration awarded Neurocrine Biosciences, Inc., a biopharmaceutical company, a delivery order contract worth $403,531.20 for the provision of VALBENAZINE 40mg and 80mg oral capsules. The contract was issued against Neurocrine's listing on the General Services Administration's Pharmaceuticals and Drugs schedule contract under the Multiple Award Schedule program. The contract had no set-aside designation and did not specify any...
This is a federal contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Neurocrine Biosciences, Inc., a biopharmaceutical company. The contract is for the delivery of VALBENAZINE oral capsules, which are used to treat neurological movement disorders. The contract was issued against Neurocrine's listing on the General Services Administration (GSA) Multiple Award Schedule Pharmaceuticals and Drugs contract (FSS-61-IB). The contract has a firm fixed price...
This federal contract award to Neurocrine Biosciences, Inc. is for the pharmaceutical product VALBENAZINE capsules, which are used to treat neurological movement disorders. The contract, valued at $468,217.20, was awarded by the Department of Veterans Affairs Veterans Health Administration's Veterans Integrated Service Network 12 and is a firm fixed price delivery order against Neurocrine's General Services Administration (GSA) Multiple Award Schedule contract for Pharmaceuticals and Drugs....
This is a firm fixed price delivery order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Neurocrine Biosciences, Inc., a biopharmaceutical company, to provide VALBENAZINE capsules used to treat neurological movement disorders. The contract was issued against Neurocrine's listing on the Pharmaceuticals and Drugs schedule contract under the General Services Administration's Multiple Award Schedule program. The contract had a potential value of...
The Department of Veterans Affairs awarded a firm fixed price delivery order contract to Neurocrine Biosciences, Inc., a biopharmaceutical company, to provide VALBENAZINE 40mg and 80mg oral capsules to the Veterans Health Administration. This contract was issued against Neurocrine's listing on the Pharmaceuticals and Drugs schedule contract under the General Services Administration's Multiple Award Schedule program. The $698,940.24 contract has no set-aside designation and is to support...
This federal contract award was issued by the Department of Veterans Affairs (VA) Veterans Health Administration to Neurocrine Biosciences, Inc., a biopharmaceutical company, to provide VALBENAZINE capsules used to treat neurological movement disorders. The contract was awarded through the VA's Pharmaceuticals and Drugs schedule contract under the General Services Administration (GSA) Multiple Award Schedule program. It was a firm fixed price, delivery order contract with a potential value of...
This is a firm fixed price delivery order awarded by the Department of Veterans Affairs (VA) to Neurocrine Biosciences, Inc., a biopharmaceutical company. The contract is for the delivery of VALBENAZINE 80mg oral capsules, a medication used to treat neurological movement disorders. The contract was issued under Neurocrine's Pharmaceuticals and Drugs schedule contract with the General Services Administration (GSA) Multiple Award Schedule program. The award has a potential value of $434,918.40 and...
This is a delivery order contract awarded by the Department of Veterans Affairs Veterans Health Administration to Neurocrine Biosciences, Inc., a biopharmaceutical company, for the supply of VALBENAZINE 40mg and 80mg oral capsules. The contract was issued against Neurocrine's listing on the Pharmaceuticals and Drugs schedule contract under the General Services Administration's Multiple Award Schedule program. The firm fixed price contract had a potential value of $497,174.64 and did not...
This contract was awarded by the Department of Veterans Affairs Veterans Health Administration to Neurocrine Biosciences, Inc., a biopharmaceutical company, for the provision of VALBENAZINE capsules. VALBENAZINE is used to treat neurological movement disorders. The contract was issued as a delivery order against Neurocrine's listing on the General Services Administration's Pharmaceuticals and Drugs schedule contract under the Multiple Award Schedule program. The contract had a firm fixed price...
This is a firm fixed price delivery order contract awarded to Neurocrine Biosciences, Inc., a biopharmaceutical company, by the Department of Veterans Affairs Veterans Health Administration. The contract, valued at $825,647.02, is for the provision of VALBENAZINE capsules, a treatment for neurological movement disorders, to various VA facilities primarily within Veterans Integrated Service Network 12 in California. The contract was issued against Neurocrine's listing on the Pharmaceuticals and...